• By doing so, the generic drugmaker limits its exposure to the end of the patent cliff.

    FORBES: Actavis Execs May Love NJ, But Ireland Has Lower Taxes

  • The goal of a generic drugmaker wouldn't be to actually overturn a big drug firm's patents.

    FORBES: Magazine Article

  • Often, that settlement comes with a sizeable payment from the brand-name company to the generic drugmaker.

    NPR: Court: Can Drug Companies Pay To Delay Generics?

  • Meanwhile, generic drugmaker Watson Pharmaceuticals has filed its own suit against Bristol-Myers over BuSpar.

    FORBES: Focus On The Forbes 500s

  • But another generic drugmaker, Bedford Labs , came out of nowhere with its own announcement to make paclitaxel.

    FORBES: Ivax Won't Make Much From The Government Deal

  • Ranbaxy, a generic drugmaker in Gurgaon, India, was looking to make knockoffs, arguing that two Lipitor patents were invalid.

    FORBES: Pfizer Wins Big

  • Apotex, the privately held generic drugmaker that is making the knockoff, said that Plavix generics hit the market today.

    FORBES: Plavix Pain

  • Bristol-Myers Squibb's board ousted Chief Executive PeterDolanPeter Dolan and General Counsel RichardWillardRichard Willard over their handling of negotiations with Apotex, a Canadian generic drugmaker.

    FORBES: Magazine Article

  • Generic drugmaker Ranbaxy Laboratories will make the biggest, 80-milligram dose, which is rarely used because of an increase in side effects with high doses of the drug.

    FORBES: Magazine Article

  • Bristol-Myers Squibb 's board ousted Chief Executive Peter Dolan and General Counsel Richard Willard over their handling of negotiations with Apotex, a Canadian generic drugmaker.

    FORBES: Peter Dolan Ousted

  • If generic drugmaker Andrx and the other defendants win, their stocks and profits will rise, while Astra's earnings will likely suffer and the firm could become takeover bait.

    FORBES: Hard to Swallow

  • It is the world's biggest generic drugmaker, but nearly a fifth of its sales in 2010 came from a patented blockbuster, Copaxone, a drug used to treat multiple sclerosis.

    ECONOMIST: The drugs industry

  • The antidepressant's patent runs out on Aug. 2, at which point you can bet generic drugmaker Barr Laboratories (nyse: BRL - news - people) of Pomona, N.

    FORBES: Eli Lilly's Flowers Of The Mind

  • Ranbaxy , a generic drugmaker based in Gurgaon, India, is challenging two key patents on Lipitor in the hopes of selling its own version of the drug at a lower price.

    FORBES: Pfizer's Patent Peril

  • Compared to the past few years, there will simply not be as many big-selling brand-name medicines losing patent protection, which means generic drugmakers cannot simply jumpstart growth by acquiring another generic drugmaker.

    FORBES: Actavis Execs May Love NJ, But Ireland Has Lower Taxes

  • But a year ago, generic drugmaker Barr Laboratories (nyse: BRL - news - people ) won a court case allowing it to make a copycat version of Prozac earlier than expected.

    FORBES: FDA Gives Conditional Approval To Lilly's Xigris

  • If you think a generic drugmaker supplying the government with more than a billion antibiotic pills to safeguard against anthrax outbreaks would be a sure way to make big money on the deal, you're probably wrong.

    FORBES: Magazine Article

  • Bristol-Myers Squibb was handed a defeat in a patent lawsuit, which will allow generic drugmaker Mylan Laboratories (nyse: MYL - news - people) to make a lower-cost version of BuSpar, Bristol's fifth best-selling drug.

    FORBES: Focus On The Forbes 500s

  • However, investors may be worried about patent challenges brought against Lipitor by generic drugmaker Ranbaxy Labs (nasdaq: RBXY - news - people ), even though most analysts view Ranbaxy's chances of launching a generic before 2010 as unlikely.

    FORBES: Pfizer's Tough Transition

  • Generic drugmaker Able Labs (nasdaq: ABRX - news - people ) is also high on Oberweis' list of top buys, along with chemical and pharmaceutical firm Aceto (nasdaq: ACET - news - people ) as well as medical testing company Biosite (nasdaq: BSTE - news - people ).

    FORBES: Best Letters Buy Into Small Caps

  • Billions of dollars could be lost to competitors or generic versions if a drugmaker fails to entice most patients into switching ahead of time.

    FORBES: Pills and Poker

  • Andrx (nasdaq: ADRX - news - people) was already hoping Altocor would help it become a bona fide drugmaker and escape the generic drug ghetto.

    FORBES: Magazine Article

  • Peter Dolan lost his job as Bristol's chief executive over the botched negotiation that allowed Canadian drugmaker Apotex to launch a generic version of Plavix at almost no financial risk.

    FORBES: Sanofi Remains Tight-Lipped

  • Because the drug is off patent, the drugmaker has to deal with competition and generic versions of the drug.

    FORBES: Drug Import Plan Can't Ignore Patents

  • Simply put, a brand-name drugmaker agrees to pay a settlement to a generic rival in exchange for ending patent litigation and launching a copycat medicine at a future date.

    FORBES: AstraZeneca & A Pay-To-Delay Deal The FTC Would Not Like

  • However, Pfizer points out that 61 decisions in 23 states have ruled against claims that tried to hold a brand-name drugmaker responsible for injuries allegedly caused by a generic version of Reglan.

    FORBES: Pfizer Wants Court To Rehear Generic Labeling Case And Avoid Tort Hell

  • For six months, under U.S. law, Israel-based drugmaker Teva Pharmaceutical Industries will be allowed to sell generic Zocor in widely used doses.

    FORBES: Magazine Article

  • 's first-quarter net income rose 53 percent despite growing generic drug competition as the world's second-largest drugmaker benefited from a gain related to a joint venture with China.

    NPR: Pfizer Q1 Profit Up, But Drugmaker Cuts Outlook

  • Ranbaxy, a Japanese-owned drugmaker, struggled to get regulators' approval for its generic version of Lipitor, and only won it on the day the patent expired.

    ECONOMIST: Drugmakers

  • Glaxo (nyse: GSK - news - people ), Europe's biggest drugmaker, plans to appeal the ruling, which could put generic versions on pharmacy shelves as early as the end of June.

    FORBES: Magazine Article

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定